Immunosuppressant Medications for HCM 2026-20 Review

This tender concerns the supply of immunosuppressant medications as part of a review process for HCM (likely Hospital Clínico Metropolitano or a similar healthcare institution) covering the period 2026-20. The objective is to secure a consistent and reliable supply of specific immunosuppressant drugs required for patient treatment. The tender documents will detail the exact list of medications, required dosages, quantities, packaging, and delivery schedules. The procuring entity is seeking qualified pharmaceutical suppliers or distributors capable of meeting the stringent requirements for supplying medications, including adherence to all relevant pharmaceutical regulations and quality standards. Bidders will be evaluated based on their ability to provide the specified medications, their pricing, delivery reliability, product quality, and compliance with Good Distribution Practices (GDP). The review period indicates that this procurement may be part of a larger strategic plan for medication supply management. The successful bidder will play a critical role in ensuring that patients receiving treatment at HCM have uninterrupted access to essential immunosuppressant therapies throughout the specified contract duration. Emphasis will be placed on the supplier's capacity to manage the cold chain and ensure the integrity of the medications during transport and delivery.

This is a services contract in the health and medical services, transport and logistics and general supplies sectors. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.